Why the study?
Does exogenous hydrogen sulphide improve diabetic cardiomyopathy by reversing disordered calcium-handling in sarcoplasmic reticulum in a rat model?
Population
Sprague Dawley rats with streptozotocin (STZ, 60 mg/kg, i.p.) induced diabetic model
Comparison
Sodium hydrogen sulphide vs Untreated diabetic model group and…
Design
Preclinical
Authors
Loading...
Should not yet change practice; leaves open hydrogen sulfide effects on calcium handling in diabetic cardiomyopathy.
Does exogenous hydrogen sulphide improve diabetic cardiomyopathy by reversing disordered calcium-handling in sarcoplasmic reticulum in a rat model?
Exogenous hydrogen sulphide ameliorates diabetic cardiomyopathy in rats by inhibiting abnormal calcium-handling in the sarcoplasmic reticulum and the ET-NADPH oxidase-PKCε pathway.
Dai et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: